Left Ventricular Pacing through Coronary Sinus Is Feasible and Safe for Patients with Prior Tricuspid Valve

Skevos Sideris1, Maria Drakopoulou2, George Oikonomopoulos3

  • 1Cardiology Department, Hippokration Hospital, Athens, Greece.

Insights

Left ventricular pacing via the coronary sinus is a safe and effective option for patients needing pacemakers after tricuspid valve intervention. This minimally invasive approach shows stable long-term outcomes without lead complications.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Tricuspid valve intervention can lead to tricuspid regurgitation, complicating right ventricular lead implantation.
  • Left ventricular pacing via the coronary sinus (CS) is an alternative in select cases post-tricuspid valve repair or replacement.

Purpose of the Study:

  • To evaluate the long-term clinical outcomes of left ventricular pacing using CS lead implantation in patients with prior tricuspid valve intervention.

Main Methods:

  • Retrospective study of 17 consecutive patients requiring pacemaker implantation after tricuspid valve intervention.
  • All patients received ventricular rate-responsive (VVIR) devices with CS lead implantation for atrial fibrillation and symptomatic pauses.

Main Results:

  • Successful and uncomplicated device implantations with acceptable operation and fluoroscopy times.
  • Stable lead performance (sensing, threshold, impedance) at 2-year follow-up with no lead dislodgement.
  • Mean R-wave sensing: 7.5 mV, mean pacing threshold: 1.9 V/0.4 ms, mean impedance: 743.5 Ohm.

Conclusions:

  • Left ventricular pacing via CS lead is a viable and minimally invasive option for permanent pacing in patients with tricuspid valve intervention.
  • This approach offers durable lead performance and avoids risks associated with right ventricular leads in this population.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
621
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
687
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
1.1K
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
556
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
441
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
1.8K